Diabetes

Metabolic or bariatric surgery may be more effective than standard medical treatments at controlling type 2 diabetes in patients who are obese.

Daily injection of the diabetes drug liraglutide can lead to greater weight loss when used in addition to diet and exercise.

Drug similarities increase the chance of a medication error.

Drug helps improve glycemic control of type 2 diabetes not adequately controlled on a regimen of empagliflozin or metformin alone.

If all individuals with diabetic retinopathy were treated in a timely manner, the incidence of blindness from diabetes could be decreased by 90%.

If all individuals with diabetic retinopathy were treated in a timely manner, the incidence of blindness from diabetes could be decreased by 90%.

Synjardy, a type 2 diabetes treatment, is now available by prescription in US pharmacies.

Planning brown bag consultations for your patients living with chronic diseases does not have to be a time-consuming scheduled event.

Diabetes is a chronic condition that affects more than 380 million individuals worldwide.

According to the CDC, childhood obesity has more than doubled in children and quadrupled in adolescents in the past 30 years.

The number of Americans with diabetes rose from 5.6 million in 1980 to 21 million in 2014, with an additional 8.1 million individuals still undiagnosed.

Which OTC products should these pharmacists recommend?

Pharmacists are making a real difference in their communities and having a significant impact on the health care team.

As part of their Diabetes Awareness Month activities, supermarket partners Ralphs and Food 4 Less will conduct a check stand donation program to benefit the American Diabetes Association

Device identifies diabetes risk, in addition to diagnosing and monitoring patients.

Study examines the potential impact from GLP-1 agonists, or incretin mimetics to treat diabetes.

Roche has launched a new HbA1C test to identify diabetes risk and diagnose and monitor patients with diabetes.

Taking hypertension medications at bedtime can improve blood pressure control and reduce the risk of developing diabetes.

Guidelines include risk classification system to remind caregivers to examine diabetics' feet.

Around 11% of patients who use insulin have adverse drug reactions.

Lixisenatide is a once-daily prandial glucagon-like peptide-1 (GLP-1) receptor agonist.

The FDA is considering approval for Sanofi's lixisenatide type 2 diabetes treatment.

Tresiba and Ryzodeg were originally denied approval due to adverse cardiovascular effects.

Eli Lilly and Company has entered into a settlement agreement to resolve patent litigation with Sanofi regarding its insulin glargine product, Basaglar.

Discovery could lead to treatments that stop cancer recurrence.